齊永芬檢視原始碼討論檢視歷史
 |
齊永芬，男，北京大學基礎醫學院教授。
學術任職
目前擔任中國病理生理學會動脈粥樣硬化專業委員會常務委員、國際動脈粥樣硬化學會中國分會理事，中國病理生理學會生物活性小分子專業委員會委員，中國生理學會應激專業委員會委員。
獲獎情況
主持過國家自然科學基金重大血管研究計劃重點項目、以及多項面上項目等。先後以第1完成人獲教育部科學技術成果二等獎、華夏醫學二等獎、中華醫學科技獎三等獎以及北京市科技成果三等獎。
學術成果
論著
Zhu Q, Ni XQ , Lu WW, Zhang JS, Ren JL, Wu D , Chen Y , Zhang LS , Yu YR, Tang CS, Qi YF*. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway. Atherosclerosis. 2017;266:212-222.
Lu WW, Jia LX, Ni XQ, Zhao L, Chang JR, Zhang JS, Hou YL, Zhu Y, Guan YF, Yu YR, Du J, Tang CS, Qi YF*.Intermedin1-53 attenuates abdominal aortic aneurysm by inhibiting oxidative stress.Arterioscler Thromb Vasc Biol. 2016;36(11):2176-2190.
Chang JR, Guo J, Wang Y, Hou YL, Lu WW, Zhang JS, , Yu YR, Xu MJ, Liu XY, Wang XJ, Guan YF, Zhu Y, Du J, Tang CS, Qi YF*. Intermedin 1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of alpha-Klotho.Kidney Int. 2016;89(3):586-600.
Lu WW, Zhao L, Zhang JS, Hou YL, Yu YR, Jia MZ, Tang CS, Qi YF*.Intermedin1-53 protects against cardiac hypertrophy by inhibiting endoplasmic reticulum stress via activating AMP-activated protein kinase. J Hypertens. 2015;33(8):1676-87.
Teng X, Song J, Zhang G, Cai Y, Yuan F, Du J, Tang C, Qi Y*. Inhibition of endoplasmic reticulum stress by intermedin(1-53) protects against myocardial injury through a PI3 kinase-Akt signaling pathway.J Mol Med (Berl). 2011; 89(12):1195-1205.
Cai Y, Xu MJ, Teng X, Zhou YB, Chen L, Zhu Y, Wang X, Tang CS, Qi YF*. Intermedin Inhibits Vascular Calcification by Increasing the Level of Matrix {gamma}-carboxyglutamic Acid Protein.Cardiovasc Res. 2010; 85: 864–873[1]